Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT

NCT00586274 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

FANCONI ANEMIA

Interventions

PROCEDURE: CD34 selected haploidentical PBSCT
DRUG: Fludarabine
BIOLOGICAL: T cell infusion
BIOLOGICAL: Campath 1h
BIOLOGICAL: anti-CD45

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]